Mycophenolate mofetil in Crohn's disease

Lancet

Volumn 356, Issue 9224, 2000, Pages 163-164

  Rampton, D S ^a   Neurath, M F ^a   Almer, S ^a   D'Haens, G ^a   Petritsch, W ^a   Stange, E F ^a  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; INFLIXIMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; LETTER; MULTICENTER STUDY; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

EID: 0034622271     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)73176-7     Document Type: Letter

References (5)

1. PW Lowry WJ Sandborn JJ Lipsky Mycophenolate mofetil for Crohn's disease? Lancet 354 1999 3 4
2. P Fickert TA Hinterleitner HH Wenzl BW Aichbichler W Petrisch Mycophenolate mofetil in patients with Crohn's disease Am J Gastroenterol 93 1998 2529 2532
3. M Neurath R Wanitschke M Peters F Krummenauer Zum Meyer K‐H Büschenfelde JF Schlaak Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease Gut 44 1999 625 628
4. K Fellermann M Steffen J Stein Mycophenolate mofetil: lack of effect in chronic active inflammatory bowel disease Aliment Pharmacol Ther 14 2000 171 176
5. PV Hassard EA Vasiliauskas LY Kam SR Targan MT Abreu Efficacy of mycophenolate mofetil in patients failing 6‐mercaptopurine and azathioprine therapy for Crohn's disease Inflamm Bowel Dis 6 2000 16 20